121 related articles for article (PubMed ID: 37577960)
1. Effects of antimicrobial therapy duration and class on risk of antimicrobial-resistant Gram-negative bacillus bloodstream infection in patients with AML.
Huggins J; Barnett I; David MZ
Transpl Infect Dis; 2023 Dec; 25(6):e14115. PubMed ID: 37577960
[TBL] [Abstract][Full Text] [Related]
2. Carbapenem-resistant
Ruvinsky S; Voto C; Roel M; Deschutter V; Ferraro D; Aquino N; Reijtman V; Galvan ME; Motto E; García M; Sarkis C; Bologna R
Front Public Health; 2022; 10():983174. PubMed ID: 36091556
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic strategies and clinical outcomes for patients with carbapenem-resistant Gram-negative bacterial bloodstream infection.
Qu J; Feng C; Li H; Lv X
Int J Antimicrob Agents; 2021 Mar; 57(3):106284. PubMed ID: 33484833
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study.
Ting SW; Lee CH; Liu JW
J Microbiol Immunol Infect; 2018 Oct; 51(5):621-628. PubMed ID: 28732563
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients Undergoing Leukemia Induction or Hematopoietic Stem-Cell Transplantation.
Webb BJ; Healy R; Majers J; Burr Z; Gazdik M; Lopansri B; Hoda D; Petersen FB; Ford C
Clin Infect Dis; 2017 Jun; 64(12):1753-1759. PubMed ID: 28369204
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors and Outcomes of Antibiotic-resistant Pseudomonas aeruginosa Bloodstream Infection in Adult Patients With Acute Leukemia.
Zhao Y; Lin Q; Liu L; Ma R; Chen J; Shen Y; Zhu G; Jiang E; Mi Y; Han M; Wang J; Feng S
Clin Infect Dis; 2020 Dec; 71(Suppl 4):S386-S393. PubMed ID: 33367574
[TBL] [Abstract][Full Text] [Related]
7. Impact of Penicillin Allergy on Empirical Carbapenem Use in Gram-Negative Bloodstream Infections: An Antimicrobial Stewardship Opportunity.
Al-Hasan MN; Acker EC; Kohn JE; Bookstaver PB; Justo JA
Pharmacotherapy; 2018 Jan; 38(1):42-50. PubMed ID: 29105102
[TBL] [Abstract][Full Text] [Related]
8. Impact of cefepime therapy on mortality among patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Chopra T; Marchaim D; Veltman J; Johnson P; Zhao JJ; Tansek R; Hatahet D; Chaudhry K; Pogue JM; Rahbar H; Chen TY; Truong T; Rodriguez V; Ellsworth J; Bernabela L; Bhargava A; Yousuf A; Alangaden G; Kaye KS
Antimicrob Agents Chemother; 2012 Jul; 56(7):3936-42. PubMed ID: 22547616
[TBL] [Abstract][Full Text] [Related]
9. Attributable mortality of ICU-acquired bloodstream infections: Impact of the source, causative micro-organism, resistance profile and antimicrobial therapy.
Adrie C; Garrouste-Orgeas M; Ibn Essaied W; Schwebel C; Darmon M; Mourvillier B; Ruckly S; Dumenil AS; Kallel H; Argaud L; Marcotte G; Barbier F; Laurent V; Goldgran-Toledano D; Clec'h C; Azoulay E; Souweine B; Timsit JF;
J Infect; 2017 Feb; 74(2):131-141. PubMed ID: 27838521
[TBL] [Abstract][Full Text] [Related]
10. Dissecting bloodstream infections in febrile neutropenic patients with hematological malignancies, a decade-long single center retrospective observational study (2009-2019).
El Omri H; Padmanabhan R; Taha RY; Kassem N; Elsabah H; Ellahie AY; Santimano AJJ; Al-Maslamani MA; Omrani AS; Elomri A; El Omri A
J Infect Public Health; 2024 Jan; 17(1):152-162. PubMed ID: 38029491
[TBL] [Abstract][Full Text] [Related]
11. Impact of the Inclusion of an Aminoglycoside to the Initial Empirical Antibiotic Therapy for Gram-Negative Bloodstream Infections in Hematological Neutropenic Patients: a Propensity-Matched Cohort Study (AMINOLACTAM Study).
Albasanz-Puig A; Gudiol C; Puerta-Alcalde P; Ayaz CM; Machado M; Herrera F; Martín-Dávila P; Laporte-Amargós J; Cardozo C; Akova M; Álvarez-Uría A; Torres D; Fortún J; García-Vidal C; Muñoz P; Bergas A; Pomares H; Mercadal S; Durà-Miralles X; García-Lerma E; Pallarès N; Carratalà J
Antimicrob Agents Chemother; 2021 Jul; 65(8):e0004521. PubMed ID: 33972253
[TBL] [Abstract][Full Text] [Related]
12. Evaluating antimicrobial duration for Gram-negative bacteremia in patients with neutropenia due to hematologic malignancy or hematopoietic stem cell transplantation.
Ranganath N; Yetmar ZA; McCandless AR; Rivera CG; Lahr BD; Tande AJ; Shah AS
Transpl Infect Dis; 2023 Oct; 25(5):e14085. PubMed ID: 37279240
[TBL] [Abstract][Full Text] [Related]
13. Influx of multidrug-resistant, gram-negative bacteria in the hospital setting and the role of elderly patients with bacterial bloodstream infection.
Pop-Vicas A; Tacconelli E; Gravenstein S; Lu B; D'Agata EM
Infect Control Hosp Epidemiol; 2009 Apr; 30(4):325-31. PubMed ID: 19220162
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary-care hospital in China: an eight-year retrospective study.
Chen J; Ma H; Huang X; Cui Y; Peng W; Zhu F; Ma S; Rao M; Zhang P; Yang H; Su L; Niu R; Pan P
Antimicrob Resist Infect Control; 2022 Dec; 11(1):161. PubMed ID: 36536423
[TBL] [Abstract][Full Text] [Related]
15. Enteric gram-negative bacilli bloodstream infections: 17 years' experience in a neonatal intensive care unit.
Cordero L; Rau R; Taylor D; Ayers LW
Am J Infect Control; 2004 Jun; 32(4):189-95. PubMed ID: 15175611
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic rotation strategies to reduce antimicrobial resistance in Gram-negative bacteria in European intensive care units: study protocol for a cluster-randomized crossover controlled trial.
van Duijn PJ; Bonten MJ
Trials; 2014 Jul; 15():277. PubMed ID: 25011604
[TBL] [Abstract][Full Text] [Related]
17. Carriage of antibiotic-resistant Gram-negative bacteria after discontinuation of selective decontamination of the digestive tract (SDD) or selective oropharyngeal decontamination (SOD).
de Jonge E; de Wilde RBP; Juffermans NP; Oostdijk EAN; Bernards AT; van Essen EHR; Kuijper EJ; Visser CE; Kesecioglu J; Bonten MJM
Crit Care; 2018 Sep; 22(1):243. PubMed ID: 30268133
[TBL] [Abstract][Full Text] [Related]
18. Impact of multiresistance of gram-negative bacteria in bloodstream infection on mortality rates and length of stay.
Sostarich AM; Zolldann D; Haefner H; Luetticken R; Schulze-Roebecke R; Lemmen SW
Infection; 2008 Feb; 36(1):31-5. PubMed ID: 18231721
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of nomograms for predicting the risk probability of carbapenem resistance and 28-day all-cause mortality in gram-negative bacteremia among patients with hematological diseases.
Jian X; Du S; Zhou X; Xu Z; Wang K; Dong X; Hu J; Wang H
Front Cell Infect Microbiol; 2022; 12():969117. PubMed ID: 36683699
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Cefepime-Cefpirome and Carbapenem Therapy for Acinetobacter Bloodstream Infection in a Multicenter Study.
Chang YY; Yang YS; Wu SL; Wang YC; Chen TL; Lee YT;
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32179523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
